Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYEli Lilly and Company | 728.85 B USD | 767.76 USD | +1.35% | 9.94 M | 3.01 | 83.99 | 9.14 USD | +68.74% | 0.68% | Health technology | Buy |
NVONovo Nordisk A/S DR | 361.86 B USD | 85.00 USD | −17.83% | 53.76 M | 10.36 | 27.56 | 3.08 USD | +28.16% | 1.21% | Health technology | Buy |
JNJJohnson & Johnson | 347.83 B USD | 144.47 USD | +0.62% | 17.7 M | 1.92 | 23.88 | 6.05 USD | +15.46% | 3.40% | Health technology | Buy |
ABBVAbbVie Inc. | 310.27 B USD | 175.58 USD | +2.37% | 18.95 M | 3.12 | 61.23 | 2.87 USD | −21.52% | 3.53% | Health technology | Buy |
MRKMerck & Company, Inc. | 248.03 B USD | 98.05 USD | −1.48% | 29.29 M | 2.20 | 20.54 | 4.77 USD | +165.21% | 3.14% | Health technology | Buy |
AZNAstraZeneca PLC DR | 198.8 B USD | 65.35 USD | +1.41% | 9.08 M | 1.55 | 31.40 | 2.08 USD | +10.04% | 2.23% | Health technology | Buy |
NVSNovartis AG DR | 191.06 B USD | 97.11 USD | +0.35% | 1.55 M | 1.40 | 11.33 | 8.57 USD | +130.62% | 3.29% | Health technology | Neutral |
PFEPfizer, Inc. | 149.38 B USD | 26.36 USD | +2.29% | 116.34 M | 2.71 | 35.43 | 0.74 USD | −59.14% | 6.37% | Health technology | Buy |
SNYSanofi DR | 118.67 B USD | 47.71 USD | +0.44% | 2.49 M | 0.86 | 26.30 | 1.81 USD | −49.14% | 3.10% | Health technology | Buy |
BMYBristol-Myers Squibb Company | 116.28 B USD | 57.33 USD | +1.83% | 48.21 M | 4.30 | — | −3.60 USD | −191.22% | 4.19% | Health technology | Neutral |
VRTXVertex Pharmaceuticals Incorporated | 102.31 B USD | 397.27 USD | +0.16% | 6.2 M | 3.24 | — | −1.99 USD | −114.96% | 0.00% | Health technology | Buy |
REGNRegeneron Pharmaceuticals, Inc. | 77.13 B USD | 701.85 USD | −0.90% | 1.89 M | 2.00 | 17.37 | 40.41 USD | +15.25% | 0.00% | Health technology | Buy |
ZTSZoetis Inc. | 74.37 B USD | 164.84 USD | +0.81% | 6.22 M | 2.66 | 30.99 | 5.32 USD | +8.17% | 1.05% | Health technology | Strong buy |
GSKGSK plc DR | 67.34 B USD | 33.60 USD | +0.51% | 6.81 M | 1.59 | 21.86 | 1.54 USD | −57.75% | 4.59% | Health technology | Neutral |
TAKTakeda Pharmaceutical Company Limited DR | 41.31 B USD | 13.10 USD | +0.69% | 1.85 M | 1.17 | 21.73 | 0.60 USD | +36.22% | 4.84% | Health technology | Buy |
ALNYAlnylam Pharmaceuticals, Inc. | 31.66 B USD | 245.44 USD | +2.75% | 1.66 M | 2.68 | — | −2.62 USD | +36.82% | 0.00% | Health technology | Buy |
BIIBBiogen Inc. | 21.34 B USD | 146.47 USD | −0.62% | 5.78 M | 3.91 | 13.23 | 11.07 USD | +10.06% | 0.00% | Health technology | Buy |
BGNEBeiGene, Ltd. DR | 19.64 B USD | 176.50 USD | +1.02% | 368.47 K | 0.71 | — | −8.24 USD | +11.11% | 0.00% | Health technology | Strong buy |
UTHRUnited Therapeutics Corporation | 16.05 B USD | 359.58 USD | −0.16% | 1.01 M | 3.35 | 15.79 | 22.77 USD | +25.44% | 0.00% | Health technology | Buy |
VTRSViatris Inc. | 14.94 B USD | 12.52 USD | +3.22% | 56.55 M | 7.22 | — | −0.74 USD | −148.99% | 3.83% | Health technology | Neutral |
RPRXRoyalty Pharma plc | 14.68 B USD | 24.92 USD | +2.64% | 7.57 M | 2.24 | 9.75 | 2.56 USD | +538.81% | 3.37% | Health technology | Strong buy |
NBIXNeurocrine Biosciences, Inc. | 13.71 B USD | 135.42 USD | +0.34% | 2.27 M | 2.17 | 36.28 | 3.73 USD | +99.71% | 0.00% | Health technology | Strong buy |
GMABGenmab A/S DR | 13.34 B USD | 20.31 USD | +1.10% | 1.83 M | 1.57 | 19.56 | 1.04 USD | +10.05% | 0.00% | Health technology | Buy |
INCYIncyte Corporation | 13.26 B USD | 68.84 USD | +2.65% | 6.81 M | 3.62 | 487.54 | 0.14 USD | −92.50% | 0.00% | Health technology | Buy |
RDYDr. Reddy's Laboratories Ltd DR | 13.15 B USD | 15.37 USD | +1.65% | 2.25 M | 1.50 | 20.04 | 0.77 USD | +3.36% | 0.53% | Health technology | Neutral |
INSMInsmed Incorporated | 12.6 B USD | 70.44 USD | +1.48% | 5.93 M | 3.13 | — | −5.56 USD | −5.41% | 0.00% | Health technology | Strong buy |
SRPTSarepta Therapeutics, Inc. | 11.36 B USD | 118.97 USD | −0.42% | 1.95 M | 2.79 | 98.83 | 1.20 USD | — | 0.00% | Health technology | Strong buy |
EXELExelixis, Inc. | 9.51 B USD | 33.29 USD | −1.16% | 7.65 M | 4.05 | 21.21 | 1.57 USD | +459.23% | 0.00% | Health technology | Buy |
ITCIIntra-Cellular Therapies Inc. | 8.85 B USD | 83.45 USD | −0.82% | 1.12 M | 2.22 | — | −0.86 USD | +47.14% | 0.00% | Health technology | Strong buy |
ROIVRoivant Sciences Ltd. | 8.42 B USD | 11.57 USD | +0.61% | 16 M | 3.66 | 2.05 | 5.66 USD | — | 0.00% | Health technology | Strong buy |
ASNDAscendis Pharma A/S DR | 8.15 B USD | 136.38 USD | −0.99% | 690.27 K | 1.55 | — | −8.10 USD | +28.89% | 0.00% | Health technology | Strong buy |
RGENRepligen Corporation | 8.09 B USD | 144.46 USD | −1.42% | 1.58 M | 3.14 | — | −0.15 USD | −108.32% | 0.00% | Health technology | Buy |
JAZZJazz Pharmaceuticals plc | 7.43 B USD | 122.97 USD | +0.10% | 1.77 M | 2.72 | 17.71 | 6.94 USD | +1,051.97% | 0.00% | Health technology | Strong buy |
MDGLMadrigal Pharmaceuticals, Inc. | 6.73 B USD | 308.44 USD | +5.12% | 716.86 K | 2.19 | — | −25.07 USD | −30.31% | 0.00% | Health technology | Strong buy |
LEGNLegend Biotech Corporation DR | 6.25 B USD | 34.08 USD | +0.18% | 1.64 M | 1.01 | — | −1.91 USD | +35.99% | 0.00% | Health technology | Strong buy |
GRFSGrifols, S.A. DR | 5.95 B USD | 7.51 USD | −2.72% | 1.8 M | 1.98 | — | — | — | 0.00% | Health technology | Neutral |
CYTKCytokinetics, Incorporated | 5.77 B USD | 48.87 USD | +4.56% | 3.81 M | 3.63 | — | −5.39 USD | +2.40% | 0.00% | Health technology | Buy |
IONSIonis Pharmaceuticals, Inc. | 5.63 B USD | 35.63 USD | +0.11% | 4.06 M | 2.48 | — | −2.44 USD | +14.63% | 0.00% | Health technology | Buy |
CORTCorcept Therapeutics Incorporated | 5.39 B USD | 51.40 USD | +0.49% | 2.46 M | 2.72 | 40.88 | 1.26 USD | +55.35% | 0.00% | Health technology | Strong buy |
TGTXTG Therapeutics, Inc. | 5.01 B USD | 32.20 USD | +4.04% | 2.79 M | 1.24 | — | −0.11 USD | +60.71% | 0.00% | Health technology | Strong buy |
CRNXCrinetics Pharmaceuticals, Inc. | 4.97 B USD | 53.60 USD | +1.63% | 1.94 M | 2.32 | — | −3.72 USD | −2.14% | 0.00% | Health technology | Strong buy |
ALKSAlkermes plc | 4.81 B USD | 29.71 USD | −0.87% | 4.64 M | 2.63 | 15.13 | 1.96 USD | +59.05% | 0.00% | Health technology | Buy |
VKTXViking Therapeutics, Inc. | 4.71 B USD | 42.25 USD | +1.83% | 8.84 M | 2.24 | — | −0.94 USD | −1.31% | 0.00% | Health technology | Strong buy |
APLSApellis Pharmaceuticals, Inc. | 4.13 B USD | 33.21 USD | +0.21% | 3.73 M | 1.20 | — | −2.04 USD | +61.20% | 0.00% | Health technology | Buy |
RAREUltragenyx Pharmaceutical Inc. | 4.08 B USD | 44.22 USD | +1.73% | 1.73 M | 2.01 | — | −6.46 USD | +28.02% | 0.00% | Health technology | Strong buy |
PBHPrestige Consumer Healthcare Inc. | 3.89 B USD | 78.72 USD | +0.08% | 604.98 K | 2.21 | 19.18 | 4.11 USD | — | 0.00% | Health technology | Buy |
OGNOrganon & Co. | 3.75 B USD | 14.58 USD | +0.97% | 31.64 M | 8.28 | 2.89 | 5.04 USD | +120.60% | 7.68% | Health technology | Neutral |
BHVNBiohaven Ltd. | 3.67 B USD | 36.26 USD | +2.60% | 3.23 M | 2.83 | — | −9.35 USD | −37.39% | 0.00% | Health technology | Strong buy |
PTCTPTC Therapeutics, Inc. | 3.57 B USD | 46.24 USD | +2.19% | 1.43 M | 2.28 | — | −5.94 USD | +31.43% | 0.00% | Health technology | Buy |
PRGOPerrigo Company plc | 3.51 B USD | 25.75 USD | +0.08% | 2.57 M | 2.11 | — | −1.11 USD | −34,712.50% | 4.29% | Health technology | Strong buy |
VRNAVerona Pharma plc DR | 3.44 B USD | 42.02 USD | +1.94% | 733.7 K | 0.91 | — | −1.94 USD | −197.56% | 0.00% | Health technology | Strong buy |
MLTXMoonLake Immunotherapeutics | 3.33 B USD | 52.17 USD | +0.56% | 192.79 K | 0.92 | — | −1.29 USD | −36.77% | 0.00% | Health technology | Strong buy |
XENEXenon Pharmaceuticals Inc. | 2.95 B USD | 38.63 USD | −0.69% | 1.11 M | 2.81 | — | −2.81 USD | −5.62% | 0.00% | Health technology | Strong buy |
FOLDAmicus Therapeutics, Inc. | 2.93 B USD | 9.80 USD | +0.72% | 4.08 M | 1.12 | — | −0.35 USD | +41.95% | 0.00% | Health technology | Strong buy |
ACADACADIA Pharmaceuticals Inc. | 2.81 B USD | 16.87 USD | +0.84% | 4.94 M | 2.78 | 21.84 | 0.77 USD | — | 0.00% | Health technology | Buy |
VCELVericel Corporation | 2.79 B USD | 56.50 USD | +2.82% | 720.65 K | 1.94 | 904.00 | 0.06 USD | — | 0.00% | Health technology | Strong buy |
NAMSNewAmsterdam Pharma Company N.V. | 2.72 B USD | 25.50 USD | +0.16% | 1.03 M | 0.49 | — | — | — | 0.00% | Health technology | Strong buy |
CPRXCatalyst Pharmaceuticals, Inc. | 2.54 B USD | 21.27 USD | −0.89% | 1.75 M | 2.12 | 18.15 | 1.17 USD | +122.28% | 0.00% | Health technology | Strong buy |
HCMHUTCHMED (China) Limited DR | 2.48 B USD | 14.31 USD | −2.05% | 81.47 K | 1.06 | — | −0.25 USD | −16.10% | 0.00% | Health technology | Strong buy |
AMRXAmneal Pharmaceuticals, Inc. | 2.41 B USD | 7.78 USD | +0.39% | 1.66 M | 1.62 | — | −0.68 USD | −1,181.67% | 0.00% | Health technology | Buy |
CNTACentessa Pharmaceuticals plc DR | 2.26 B USD | 17.16 USD | −2.22% | 791.27 K | 1.02 | — | −1.53 USD | +7.72% | 0.00% | Health technology | Strong buy |
IDYAIDEAYA Biosciences, Inc. | 2.21 B USD | 25.61 USD | +3.31% | 2.02 M | 2.54 | — | −2.33 USD | −19.54% | 0.00% | Health technology | Strong buy |
LGNDLigand Pharmaceuticals Incorporated | 2.17 B USD | 114.64 USD | +0.61% | 551.6 K | 4.59 | 45.61 | 2.51 USD | +200.39% | 0.00% | Health technology | Strong buy |
AKROAkero Therapeutics, Inc. | 2.05 B USD | 29.34 USD | +3.31% | 1.56 M | 2.87 | — | −3.75 USD | −59.03% | 0.00% | Health technology | Strong buy |
TARSTarsus Pharmaceuticals, Inc. | 2.02 B USD | 52.91 USD | +1.75% | 816.37 K | 1.43 | — | −3.81 USD | +0.54% | 0.00% | Health technology | Strong buy |
AGIOAgios Pharmaceuticals, Inc. | 2.02 B USD | 35.42 USD | −1.09% | 3.2 M | 2.16 | 3.12 | 11.37 USD | — | 0.00% | Health technology | Buy |
MIRMMirum Pharmaceuticals, Inc. | 1.99 B USD | 41.51 USD | +0.92% | 1.19 M | 2.64 | — | −2.07 USD | +52.00% | 0.00% | Health technology | Strong buy |
BLTEBelite Bio, Inc DR | 1.98 B USD | 64.12 USD | +1.07% | 57.49 K | 1.08 | — | −1.11 USD | — | 0.00% | Health technology | Strong buy |
SUPNSupernus Pharmaceuticals, Inc. | 1.96 B USD | 35.43 USD | −0.95% | 1.06 M | 3.28 | 33.17 | 1.07 USD | +175.07% | 0.00% | Health technology | Buy |
HRMYHarmony Biosciences Holdings, Inc. | 1.96 B USD | 34.28 USD | +1.15% | 2.98 M | 6.33 | 16.23 | 2.11 USD | −14.38% | 0.00% | Health technology | Strong buy |
SLNOSoleno Therapeutics, Inc. | 1.95 B USD | 45.18 USD | −0.04% | 1.28 M | 2.00 | — | −3.31 USD | −2.66% | 0.00% | Health technology | Strong buy |
IBRXImmunityBio, Inc. | 1.91 B USD | 2.62 USD | −1.87% | 7.89 M | 0.89 | — | −0.89 USD | +15.29% | 0.00% | Health technology | Buy |
MNKDMannKind Corporation | 1.89 B USD | 6.85 USD | +8.73% | 7.22 M | 2.42 | 97.44 | 0.07 USD | — | 0.00% | Health technology | Strong buy |
AMPHAmphastar Pharmaceuticals, Inc. | 1.88 B USD | 39.14 USD | −0.63% | 2.48 M | 4.34 | 13.02 | 3.01 USD | +17.33% | 0.00% | Health technology | Buy |
ARQTArcutis Biotherapeutics, Inc. | 1.75 B USD | 14.99 USD | +6.24% | 5.22 M | 2.36 | — | −1.79 USD | +59.00% | 0.00% | Health technology | Strong buy |
NMRANeumora Therapeutics, Inc. | 1.75 B USD | 10.85 USD | +3.33% | 1.9 M | 2.20 | — | −1.85 USD | −80.83% | 0.00% | Health technology | Strong buy |
EVOEvotec SE DR | 1.54 B USD | 4.47 USD | +1.59% | 1.73 M | 12.00 | — | −0.52 USD | +5.42% | 0.00% | Health technology | Buy |
VRDNViridian Therapeutics, Inc. | 1.51 B USD | 19.03 USD | +1.60% | 4.98 M | 2.28 | — | −4.31 USD | +15.56% | 0.00% | Health technology | Strong buy |
TVTXTravere Therapeutics, Inc. | 1.5 B USD | 17.18 USD | −1.26% | 3.7 M | 2.82 | — | −4.56 USD | −3.48% | 0.00% | Health technology | Strong buy |
KNSAKiniksa Pharmaceuticals, Ltd. | 1.49 B USD | 20.59 USD | +0.49% | 592.65 K | 2.03 | — | −0.14 USD | −32.91% | 0.00% | Health technology | Strong buy |
INDVIndivior PLC | 1.46 B USD | 11.66 USD | +1.04% | 1.66 M | 1.17 | — | −0.04 USD | +97.57% | 0.00% | Health technology | Strong buy |
PRAXPraxis Precision Medicines, Inc. | 1.43 B USD | 76.52 USD | +5.05% | 530.84 K | 1.13 | — | −10.30 USD | +69.41% | 0.00% | Health technology | Strong buy |
NRIXNurix Therapeutics, Inc. | 1.4 B USD | 19.83 USD | −1.05% | 2.91 M | 2.96 | — | −2.91 USD | −5.94% | 0.00% | Health technology | Strong buy |
OCULOcular Therapeutix, Inc. | 1.34 B USD | 8.50 USD | +0.59% | 1.43 M | 2.03 | — | −1.32 USD | −18.71% | 0.00% | Health technology | Strong buy |
DAWNDay One Biopharmaceuticals, Inc. | 1.29 B USD | 12.79 USD | +2.65% | 2.28 M | 2.57 | — | −1.01 USD | +55.62% | 0.00% | Health technology | Strong buy |
HROWHarrow, Inc. | 1.22 B USD | 34.22 USD | −0.61% | 554.34 K | 1.65 | — | −0.94 USD | −108.90% | 0.00% | Health technology | Strong buy |
ARDXArdelyx, Inc. | 1.14 B USD | 4.82 USD | +2.77% | 5.04 M | 1.15 | — | −0.31 USD | −149.72% | 0.00% | Health technology | Strong buy |
INVAInnoviva, Inc. | 1.12 B USD | 17.84 USD | −0.50% | 2.4 M | 3.92 | 25.94 | 0.69 USD | +55.68% | 0.00% | Health technology | Buy |
SPRYARS Pharmaceuticals, Inc. | 1.09 B USD | 11.18 USD | −1.24% | 2.58 M | 2.24 | — | −0.51 USD | +79.10% | 0.00% | Health technology | Strong buy |
SEPNSepterna, Inc. | 1.08 B USD | 24.28 USD | +3.76% | 4.29 M | 11.71 | — | — | — | 0.00% | Health technology | Strong buy |
PHVSPharvaris N.V. | 1.06 B USD | 19.57 USD | +2.95% | 97.07 K | 1.35 | — | −2.68 USD | +16.70% | 0.00% | Health technology | Strong buy |
AVDLAvadel Pharmaceuticals plc | 993.49 M USD | 10.31 USD | +1.98% | 1.17 M | 1.08 | — | −0.77 USD | +64.19% | 0.00% | Health technology | Strong buy |
ZYMEZymeworks Inc. | 982 M USD | 14.14 USD | +4.12% | 1.61 M | 3.19 | — | −1.51 USD | −148.37% | 0.00% | Health technology | Buy |
COLLCollegium Pharmaceutical, Inc. | 957.83 M USD | 29.70 USD | −2.43% | 1.38 M | 2.88 | 12.81 | 2.32 USD | +1,442.05% | 0.00% | Health technology | Buy |
BBCAXBicara Therapeutics Inc. | 957.17 M USD | 17.59 USD | +5.96% | 4.29 M | 8.68 | — | — | — | 0.00% | Health technology | Strong buy |
GYREGyre Therapeutics, Inc. | 956.06 M USD | 11.14 USD | +4.50% | 198.8 K | 1.25 | — | — | — | 0.00% | Health technology | — |
LQDALiquidia Corporation | 939.47 M USD | 11.10 USD | +4.82% | 2.7 M | 3.81 | — | −1.62 USD | −82.56% | 0.00% | Health technology | Strong buy |
ETNB89bio, Inc. | 933.6 M USD | 7.94 USD | +12.94% | 4.5 M | 2.87 | — | −2.91 USD | −45.57% | 0.00% | Health technology | Buy |
LENZLENZ Therapeutics, Inc. | 897.35 M USD | 32.63 USD | +7.76% | 760.73 K | 5.34 | — | −7.07 USD | +54.85% | 0.00% | Health technology | Strong buy |
AVBPArriVent BioPharma, Inc. | 879.16 M USD | 26.09 USD | +1.72% | 662.7 K | 5.64 | — | −2.42 USD | −38.12% | 0.00% | Health technology | Strong buy |